Arizona Cancer Center

Phase	Trial [desc]	Trial Status	Site Status	Drug	NCT#
1	Study to Assess the Safety of Escalating Doses of AT13387 in Patients With Metastatic Solid Tumors	Completed	Closed	AT13387	NCT00878423
2	A Study to Investigate the Safety and Efficacy of AT13387, Alone or in Combination With Imatinib, in Patients With GIST	Completed	Closed	Imatinib + AT13387	NCT01294202
1	A Phase I Open Label, Safety, Pharmacokinetic and Pharmacodynamic Dose Escalation Study in SF1126, a PI Kinase (PI3K) Inhibitor, Given Twice Weekly by IV Infusion to Patients With Advanced or Metastatic Tumors	Ongoing, but not recruiting	Closed	SF1126	NCT00907205
1	A Multiple Ascending Dose Study of R1507 in Children and Adolescents With Advanced Solid Tumors	Ongoing, but not recruiting	Closed	R1507	NCT00560144